BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Industrials | 6% |
| 5 | Healthcare | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Leidos
LDOS
$17.6B
| $385K | ﹤0.01% |
9,544
+1,169
| +14% | +$49.1K |
|
1402
Autoliv
ALV
$8.89B
| $383K | ﹤0.01% |
4,554
+2,952
| +184% | +$260K |
|
1403
MSCI
MSCI
$41.8B
| $383K | ﹤0.01% |
6,222
-2,323
| -27% | -$144K |
|
1404
Euronet Worldwide
EEFT
$2.78B
| $381K | ﹤0.01% |
6,169
-1,229
| -17% | -$73.1K |
|
1405
Rayonier
RYN
$6.47B
| $379K | ﹤0.01% |
16,367
+1,931
| +13% | +$45.3K |
|
1406
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
| $379K | ﹤0.01% |
6,900
| – | – |
|
1407
Ternium
TX
$10.8B
| $378K | ﹤0.01% |
21,862
-5,718
| -21% | -$113K |
|
1408
Core Laboratories
CLB
$571M
| $377K | ﹤0.01% |
3,305
-162
| -5% | -$19.6K |
|
1409
Tanger
SKT
$4.42B
| $376K | ﹤0.01% |
11,862
-5,816
| -33% | -$197K |
|
|
DYAX
1410
DELISTED
DYAX CORPORATION
DYAX
| $373K | ﹤0.01% |
14,061
+2,083
| +17% | +$55.2K |
|
1411
Agnico Eagle Mines
AEM
$91.3B
| $372K | ﹤0.01% |
13,110
+7,239
| +123% | +$225K |
|
|
WR
1412
DELISTED
Westar Energy Inc
WR
| $372K | ﹤0.01% |
10,862
-8,842
| -45% | -$323K |
|
1413
Group 1 Automotive
GPI
$3.17B
| $371K | ﹤0.01% |
4,084
+2,379
| +140% | +$203K |
|
|
EVHC
1414
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $370K | ﹤0.01% |
3,128
+1,404
| +81% | +$160K |
|
1415
Halozyme
HALO
$11.6B
| $369K | ﹤0.01% |
16,324
+6,352
| +64% | +$112K |
|
|
XHR
1416
Xenia Hotels & Resorts
XHR
$1.73B
| $367K | ﹤0.01% |
16,900
+14,265
| +541% | +$325K |
|
1417
Ingredion
INGR
$6.54B
| $366K | ﹤0.01% |
4,583
-1,026
| -18% | -$82.4K |
|
|
MLNX
1418
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $365K | ﹤0.01% |
7,512
+2
| +0% | +$97 |
|
1419
International Flavors & Fragrances
IFF
$21.4B
| $363K | ﹤0.01% |
3,317
-8,115
| -71% | -$937K |
|
1420
Strategic Education
STRA
$1.81B
| $362K | ﹤0.01% |
8,405
-5,218
| -38% | -$256K |
|
|
RJET
1421
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $362K | ﹤0.01% |
39,435
-6,886
| -15% | -$79.2K |
|
1422
Ryman Hospitality Properties
RHP
$7.82B
| $361K | ﹤0.01% |
6,797
+1,665
| +32% | +$95K |
|
1423
FMC
FMC
$1.27B
| $361K | ﹤0.01% |
7,911
+3,810
| +93% | +$189K |
|
1424
John Wiley & Sons Class A
WLY
$2.63B
| $360K | ﹤0.01% |
6,627
-4,670
| -41% | -$271K |
|
1425
Willis Towers Watson
WTW
$31B
| $359K | ﹤0.01% |
2,888
+624
| +28% | +$79.5K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.